© 2014 - 2018
ReMedDev® is a TM of
Vermilion Life Sciences Ltd
Vermilion Life Sciences was founded by Stuart Dollow to work towards new models of medicines development. Our ambition is to cut the costs and time for medicines to reach patients by Reengineering Medicines Development #ReMedDev®.
Stuart is a GMC fully registered physician who trained in General Medicine and General Practice before gaining many years experience in senior leadership roles in large and medium sized pharmaceutical companies. Stuart is Chair of the Advisory Committee on Clinical Excellence Awards, as well as a Board Trustee of the Faculty of Pharmaceutical Medicine and a Board Member of the UK's Human Tissue Authority.
He was previously a member of the UK Government's Office for Life Sciences Expert Advisory Group on Innovative Medicines, leading a work stream on the Accelerated Access Review. He is a strong motivator and strategic thinker, seeking and providing solutions beyond the obvious.
Vermilion Life Sciences offers and co-ordinates pro bono input and expertise to medical research charities through a network of experienced consultants with a range of skills and experience.
Vermilion Life Sciences. Reengineering Medicines Development #ReMedDev®
Please contact us to learn more.